pharmaceutical investing Ziopharm Oncology Completes Enrollment of Controlled IL-12 plus Opdivo Phase 1 Combination Trial
Ziopharm Oncology Responds to Recent Stock Decline and Clarifies Exclusivity Rights for Clinical Assets
Walker Lane Resources Ltd. Announces An Aeromagnetic and Radiometric Airborne Survey will be Completed on its Tule Canyon Project, Walker Lane Gold Trend, Nevada